We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 8,419 results
  1. Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort Study

    Background

    Levetiracetam is an anti-seizure medication (ASM) with an established safety profile. However, a potential safety signal of hypokalemia...

    Ohoud Almadani, Raseel Alroba, ... Adel A. Alrwisan in Drugs - Real World Outcomes
    Article Open access 03 June 2024
  2. Levetiracetam Interaction with Direct Oral Anticoagulants: A Pharmacovigilance Study

    Background

    Levetiracetam is widely used in post-stroke epilepsy. However, it is suspected to possess P-glycoprotein (P-gp) induction properties, and...

    Mohammed Abou Kaoud, Ran Nissan, ... Elad Maor in CNS Drugs
    Article 22 November 2023
  3. Levetiracetam versus Phenobarbitone for Management of Neonatal Seizures: A Systematic Review and Meta-analysis

    Objectives

    To review whether levetiracetam is non-inferior to phenobarbitone as the first-choice antiseizure medication (ASM).

    Methods

    The authors...

    Jogender Kumar, Bharti Yadav, ... Jitendra Kumar Sahu in Indian Journal of Pediatrics
    Article 08 November 2023
  4. A case of glossopharyngeal neuralgia successfully treated with levetiracetam

    Background

    Glossopharyngeal neuralgia is a condition that causes severe pain in the throat during swallowing. Although carbamazepine is a viable...

    Hiroyuki Nishie, Yuka Sakuta, Hideki Nakatsuka in JA Clinical Reports
    Article Open access 07 February 2023
  5. Effect of Levetiracetam on Cognition: A Systematic Review and Meta-analysis of Double-Blind Randomized Placebo-Controlled Trials

    Background

    Studies have suggested that levetiracetam may help improve cognitive function in patients with epilepsy. Recently, its efficacy in...

    Chia-Yen Lin, Meng-Chia Chang, Hong-Jie Jhou in CNS Drugs
    Article 15 December 2023
  6. Efficacy and Safety of Levetiracetam on the Treatment of Spasticity in Neurologic Disorders: a Systematic Review

    Spasticity is one of the disabling complications of various neurologic disorders. Its relief through available pharmacotherapy is oftentimes...

    Jane Marice S. Pascual, Karen Joy B. Adiao, Mario B. Prado Jr in SN Comprehensive Clinical Medicine
    Article 23 August 2023
  7. Enhanced renal clearance impacts levetiracetam concentrations in patients with traumatic brain injury with and without augmented renal clearance

    Background

    The purpose of this study was to examine the impact of ARC on levetiracetam concentrations during the first week following acute TBI. The...

    Aaron M. Cook, Kaylee Hall, ... Denise H. Rhoney in BMC Neurology
    Article Open access 02 January 2024
  8. Effects of sodium valproate and levetiracetam on posterior segment parameters in children with epilepsy

    Purpose

    To evaluate changes in posterior segment parameters in pediatric patients with epilepsy using sodium valproate or levetiracetam monotherapy...

    Asena Keles Sahin, Sevgi Cirakli in International Ophthalmology
    Article 08 February 2024
  9. Evaluation of Levetiracetam Dosing Strategies for Seizure Prophylaxis Following Traumatic Brain Injury

    Background

    Although levetiracetam has been increasingly used as an alternative to phenytoin for early posttraumatic seizure prophylaxis following...

    Kelsey Ohman, Bridgette Kram, ... Jordan Komisarow in Neurocritical Care
    Article 27 September 2022
  10. Levetiracetam

    Article 17 February 2024
  11. Levetiracetam

    Article 06 April 2024
  12. Levetiracetam

    Article 08 June 2024
  13. Levetiracetam

    Article 11 May 2024
  14. Levetiracetam for the treatment of mild cognitive impairment in Parkinson’s disease: a double-blind controlled proof-of-concept trial protocol

    Background

    Mild memory impairment, termed amnestic mild cognitive impairment (aMCI), is associated with rapid progression towards dementia in...

    Nadeeka Dissanayaka, Dana Pourzinal, ... Arnold Bakker in Pilot and Feasibility Studies
    Article Open access 22 November 2023
  15. Levetiracetam

    Article 08 June 2024
  16. Levetiracetam

    Article 02 March 2024
  17. Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population

    Background

    Levetiracetam is an antiseizure medication used for several seizure types in adults and children aged 1 month and older; however, due to a...

    Patricia D. Maglalang, Jaydeep Sinha, ... Paula Delmore in Clinical Pharmacokinetics
    Article 30 May 2024
  18. Levetiracetam

    Article 11 May 2024
  19. Levetiracetam

    Article 27 April 2024
Did you find what you were looking for? Share feedback.